From Biochemistry to Clinical Relevance Search J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
12 Retina Gabriele K
299 12 Retina Gabriele K. Lang and Gerhard K. Lang 12.1 Basic Knowledge The retina is the innermost of three successive layers of the globe. It comprises two parts: ❖ A photoreceptive part (pars optica retinae), comprising the first nine of the 10 layers listed below. ❖ A nonreceptive part (pars caeca retinae) forming the epithelium of the cil- iary body and iris. The pars optica retinae merges with the pars ceca retinae at the ora serrata. Embryology: The retina develops from a diverticulum of the forebrain (proen- cephalon). Optic vesicles develop which then invaginate to form a double- walled bowl, the optic cup. The outer wall becomes the pigment epithelium, and the inner wall later differentiates into the nine layers of the retina. The retina remains linked to the forebrain throughout life through a structure known as the retinohypothalamic tract. Thickness of the retina (Fig. 12.1) Layers of the retina: Moving inward along the path of incident light, the individual layers of the retina are as follows (Fig. 12.2): 1. Inner limiting membrane (glial cell fibers separating the retina from the vitreous body). 2. Layer of optic nerve fibers (axons of the third neuron). 3. Layer of ganglion cells (cell nuclei of the multipolar ganglion cells of the third neuron; “data acquisition system”). 4. Inner plexiform layer (synapses between the axons of the second neuron and dendrites of the third neuron). 5. Inner nuclear layer (cell nuclei of the bipolar nerve cells of the second neuron, horizontal cells, and amacrine cells). 6. Outer plexiform layer (synapses between the axons of the first neuron and dendrites of the second neuron). -
Current Trends in Ophthalmology Autonomic Regulation of The
Review Article Current Trends in Ophthalmology Autonomic Regulation of the Function of the Vitreous Body and Retina Lychkova AE1*, Severin AE2, Torshin VI2, Starshinov YP2, Sdobnikova SV3, Ashrafov RA4, Ashrafova SR4, Golubev YY5 Golubeva GY6 and Puzikov AM1 1Department of Health, Moscow’s Clinical Research Center, Moscow, Russia 2Russian People’s Friendship University, Moscow, Russia 3Research Institute of Eye Diseases, Moscow, Russia 4Center for Laser Surgery, Moscow, Russia 5Russian National Research Medical University, Moscow, Russia 6City Clinical Hospital, Moscow, Russia *Correspondence: Lychkova Alla Edward, Department Head of the Moscow’s Clinical Research Center, DZM, Shosse Enthusiasts 86, 111123, 11-1-53, Amundsen 129343, Moscow, Russia, Tel: (+7) 962-965-4923; E-mail: [email protected] Received: May 08, 2018; Accepted: June 25, 2018; Published: June 29, 2018 Abstract The data of the literature on the structure and physiology of the vitreous body and the retina in normal and pathological conditions are presented. The mechanism of vitreous detachment and its role in the development of vitreoretinal proliferation are described. Described adren-choline-peptide and NO-ergic mechanisms in signal transduction of the vitreous body and retina. Pharmacological and surgical methods of treatment of vitreoretinal proliferation are briefly described. Keywords: Vitreous body; Retina; Detachment; Vitreoretinal proliferation Introduction density of collagen fibers and a greater concentration of hyaluronic acid as compared to the central part. Cortical Vitreous Body (VB) is a transparent, colourless, gel- gel is comparatively more stable and more resistant to like mass containing water with an admixture of salts, age-related changes [1]. The VB contains two channels sugars, hyaluronic acid, a network of collagen fibers II, IX, (optociliary and lenticular) and three rows of cisterns, a XI types and few cells (mainly phagocytes, contributing to bursa premacularis and a precapillary space [1,3-5]. -
Vitreous and Developmental Vitreoretinopathies Kevin R
CHAPTER 3 Vitreous and Developmental Vitreoretinopathies Kevin R. Tozer, Kenneth M. P. Yee, and J. Sebag Invisible (Fig. 3.1) by design, vitreous was long unseen the central vitreous and adjacent to the anterior cortical as important in the physiology and pathology of the eye. gel. HA molecules have a different distribution from col- Recent studies have determined that vitreous plays a sig- lagen, being most abundant in the posterior cortical gel nificant role in ocular health (1) and disease (1,2), includ- with a gradient of decreasing concentration centrally ing a number of important vitreoretinal disorders that and anteriorly (6,7). arise from abnormal embryogenesis and development. Both collagen and HA are synthesized during child- Vitreous embryology is presented in detail in Chapter 1. hood. Total collagen content in the vitreous gel remains Notable is that primary vitreous is filled with blood ves- at about 0.05 mg until the third decade (8). As collagen sels during the first trimester (Fig. 3.2). During the second does not appreciably increase during this time but the trimester, these vessels begin to disappear as the second- size of the vitreous does increase with growth, the den- ary vitreous is formed, ultimately resulting in an exqui- sity of collagen fibrils effectively decreases. This could sitely clear gel (Fig. 3.1). The following will review vitreous potentially weaken the collagen network and destabilize development and the congenital disorders that arise from the gel. However, since there is active synthesis of HA abnormalities in hyaloid vessel formation and regression during this time, the dramatic increase in HA concentra- during the primary vitreous stage and biochemical abnor- tion may stabilize the thinning collagen network (9). -
Passport to Success
The following terms and other boldface terms in the chapter are defined in the Glossary accommodation choroid After careful study of this chapter, you should be able to: cochlea conjunctiva 1. Describe the function of the sensory system convergence 2. Differentiate between the special and general senses and give examples of each cornea 3. Describe the structure of the eye gustation 4. List and describe the structures that protect the eye lacrimal apparatus 5. Define refraction and list the refractive parts of the eye lens (crystalline lens) 6. Differentiate between the rods and the cones of the eye olfaction 7. Compare the functions of the extrinsic and intrinsic muscles of organ of Corti the eye ossicle 8. Describe the nerve supply to the eye proprioceptor 9. Describe the three divisions of the ear refraction 10. Describe the receptor for hearing and explain how it functions retina 11. Compare static and dynamic equilibrium and describe the sclera location and function of these receptors semicircular canal 12. Explain the function of proprioceptors sensory adaptation 13. List several methods for treatment of pain sensory receptor 14. Describe sensory adaptation and explain its value tympanic membrane 15. Show how word parts are used to build words related to the vestibule sensory system (see Word Anatomy at the end of the chapter) vitreous body PASSport to Success Visit thePoint or see the Student Resource CD in the back of this book for definitions and pronun- ciations of key terms as well as a pretest for this chapter. ® Paul’s Second Case: Seeing More of the Sun’s Effects aul glanced once again at the postcard condition, and it does have a hereditary fac- sitting on his entranceway table as he ar- tor.” The doctor dilated Paul’s eyes with drops Prived home in the evening. -
To See the Invisible: the Quest of Imaging Vitreous J
DOP42005.qxd 4/15/08 11:34 AM Page 5 Meyer CH (ed): Vital Dyes in Vitreoretinal Surgery. Dev Ophthalmol. Basel, Karger, 2008, vol 42, pp 5–28 To See the Invisible: The Quest of Imaging Vitreous J. Sebag VMR Institute, University of Southern California, Los Angeles, Calif., USA Abstract Purpose: Imaging vitreous has long been a quest to view what is, by design, invisible. This chapter will review important historical aspects, past and present imaging methodologies, and new technologies that are currently in development for future research and clinical applications. Methods: Classic and modern histologic techniques, dark-field slit microscopy, clinical slit lamp biomicroscopy, standard and scanning laser ophthalmoscopy (SLO), ultrasonography, optical coherence tomography (OCT), com- bined OCT-SLO, magnetic resonance and Raman spectroscopies, and dynamic light scattering method- ologies are presented. Results: The best available histologic techniques for imaging vitreous are those that avoid rapid dehydration of vitreous specimens. Dark-field slit microscopy enables in vitro imaging without dehydration or tissue fixatives. OCT enables better in vivo visualization of the vitreoretinal inter- face than SLO and ultrasonography, but does not adequately image the vitreous body. The combination of OCT with SLO has provided useful new imaging capabilities, but only at the vitreoretinal interface. Dynamic light scattering can evaluate the vitreous body by determining the average sizes of vitreous macromolecules in aging, disease, and as a means to assess the effects of pharmacologic vitreolysis. Raman spectroscopy can detect altered vitreous molecules, such as glycated collagen and other pro- teins in diabetic vitreopathy and possibly other diseases. Conclusions: A better understanding of normal vitreous physiology and structure and how these change in aging and disease is needed to develop more effective therapies and prevention. -
Plasma Kallikrein-Kinin System As a VEGF-Independent Mediator of Diabetic
Page 1 of 52 Diabetes Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema Takeshi Kita1, Allen C. Clermont1, Nivetha Murugesan1 Qunfang Zhou1, Kimihiko 2 2 1,3 1,4 Fujisawa , Tatsuro Ishibashi , Lloyd Paul Aiello , Edward P. Feener 1 Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA 2 Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan. 3 Beetham Eye Institute, Department of Ophthalmology, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA 4 Department of Medicine, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA Corresponding Author: Edward P. Feener, Ph.D., Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA. Phone: 617-307-2599, Fax:617-307-2637. e-mail: [email protected] 1 Diabetes Publish Ahead of Print, published online May 15, 2015 Diabetes Page 2 of 52 Abstract: This study characterizes the kallikrein kinin system in vitreous from individuals with diabetic macular edema (DME) and examines mechanisms contributing to retinal thickening and retinal vascular permeability (RVP). Plasma prekallikrein (PPK) and plasma kallikrein (PKal) were increased 2 and 11.0-fold (both p<0.0001), respectively, in vitreous from subjects with DME compared to those with macular hole (MH). While vascular endothelial growth factor (VEGF) was also increased in DME vitreous, PKal and VEGF concentrations do not correlate (r=0.266, p=0.112). Using mass spectrometry-based proteomics we identified 167 vitreous proteins, including 30 that were increased in DME (> 4-fold, p< 0.001 vs. -
An Evaluation of OPTC and EPYC As Candidate Genes for High Myopia
Molecular Vision 2009; 15:2045-2049 <http://www.molvis.org/molvis/v15/a219> © 2009 Molecular Vision Received 19 July 2009 | Accepted 12 October 2009 | Published 15 October 2009 An evaluation of OPTC and EPYC as candidate genes for high myopia Panfeng Wang, Shiqiang Li, Xueshan Xiao, Xiangming Guo, Qingjiong Zhang State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, P. R. China Purpose: The small leucine-rich repeat proteins (SLRPs) are involved in organizing the collagen fibrils of the sclera and vitreous. The shape of the eyeball is determined by the sclera and vitreous, so defects in SLRP family members may contribute to myopia. The purpose of this study was to test whether mutations in the two members of the class III SLRPs, opticin (OPTC) and dermatan sulfate proteoglycan 3 (EPYC), are responsible for high myopia. Methods: DNA was prepared from venous leukocytes of 93 patients with high myopia (refraction of spherical equivalent ≤-6.00D) and 96 controls (refraction of spherical equivalent between -0.50D and +1.00D). The coding regions and adjacent intronic sequences of OPTC and EPYC were amplified by the polymerase chain reaction (PCR), and the products were then analyzed by cycle sequencing. The detected variations were further evaluated in normal controls and available family members by a heteroduplex-single strand conformation polymorphism (heteroduplex-SSCP) analysis or sequencing. Results: Two substitutions in OPTC, including c.491G>T and c.803T>C, were identified. The c.491G>T mutation (p.Arg164Leu), a novel heterozygous variation, was detected in one of the 93 patients but in none of the 96 controls. -
Floaters-Survey-Ophthalmol-2016.Pdf
survey of ophthalmology 61 (2016) 211e227 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/survophthal Major review Vitreous floaters: Etiology, diagnostics, and management Rebecca Milston, MOptoma, Michele C. Madigan, PhDb,c, J. Sebag, MD, FACS, FRCOphth, FARVOd,* a Centre for Eye Health, University of New South Wales, Sydney, New South Wales, Australia b School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia c Save Sight Institute and Discipline of Clinical Ophthalmology, Sydney Medical School, University of Sydney, New South Wales, Australia d VMR Institute for Vitreous Macula Retina, Huntington Beach, California, USA article info abstract Article history: Vitreous is a hydrated extracellular matrix comprised primarily of water, collagens, and Received 3 July 2015 hyaluronan organized into a homogeneously transparent gel. Gel liquefaction results from Received in revised form 25 molecular alterations with dissociation of collagen from hyaluronan and aggregation of November 2015 collagen fibrils forming fibers that cause light scattering and hence symptomatic floaters, Accepted 25 November 2015 especially in myopia. With aging, gel liquefaction and weakened vitreoretinal adhesion Available online 8 December 2015 result in posterior vitreous detachment, the most common cause of primary symptomatic floaters arising from the dense collagen matrix of the posterior vitreous cortex. Recent Keywords: studies indicate that symptomatic floaters are not only more prevalent, but also have a vitreous negative impact on the quality of life that is greater than previously appreciated. We review collagen the literature concerning management of symptomatic vitreous floaters, currently either myopia with observation, vitrectomy, or Nd:YAG laser. -
Eleventh Edition
SUPPLEMENT TO April 15, 2009 A JOBSON PUBLICATION www.revoptom.com Eleventh Edition Joseph W. Sowka, O.D., FAAO, Dipl. Andrew S. Gurwood, O.D., FAAO, Dipl. Alan G. Kabat, O.D., FAAO Supported by an unrestricted grant from Alcon, Inc. 001_ro0409_handbook 4/2/09 9:42 AM Page 4 TABLE OF CONTENTS Eyelids & Adnexa Conjunctiva & Sclera Cornea Uvea & Glaucoma Viitreous & Retiina Neuro-Ophthalmic Disease Oculosystemic Disease EYELIDS & ADNEXA VITREOUS & RETINA Blow-Out Fracture................................................ 6 Asteroid Hyalosis ................................................33 Acquired Ptosis ................................................... 7 Retinal Arterial Macroaneurysm............................34 Acquired Entropion ............................................. 9 Retinal Emboli.....................................................36 Verruca & Papilloma............................................11 Hypertensive Retinopathy.....................................37 Idiopathic Juxtafoveal Retinal Telangiectasia...........39 CONJUNCTIVA & SCLERA Ocular Ischemic Syndrome...................................40 Scleral Melt ........................................................13 Retinal Artery Occlusion ......................................42 Giant Papillary Conjunctivitis................................14 Conjunctival Lymphoma .......................................15 NEURO-OPHTHALMIC DISEASE Blue Sclera .........................................................17 Dorsal Midbrain Syndrome ..................................45 -
Images in Medicine Bilateral Asteroid Hyalosis Revealing a Blood Imbalance
Open Access Images in medicine Bilateral asteroid hyalosis revealing a blood imbalance Zouheir Hafidi1,&, Rajae Daoudi1 1Université Mohammed V Souissi, Service d’Ophtalmologie A de l’hôpital des spécialités, Centre Hospitalier Universitaire, Rabat, Maroc &Corresponding author: Zouheir Hafidi, Université Mohammed V Souissi, Service d’Ophtalmologie A de l’hôpital des spécialités, Centre Hospitalier Universitaire, Rabat, Maroc Key words: Asteroid hyalosis, vitreous degeneration, retinopathy, fluorescein angiography Received: 04/09/2013 - Accepted: 04/11/2013 - Published: 09/11/2013 Pan African Medical Journal. 2013 16:87 doi:10.11604/pamj.2013.16.87.3329 This article is available online at: http://www.panafrican-med-journal.com/content/article/16/87/full © Zouheir Hafidi et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Image in medicine intravitreal injection of anti-endothelial growth factor (anti VEGF) agents. Asteroid hyalosis is an age related vitreous degeneration of unknown etiology, usually described to be unilateral. It's characterized by aggregation of calcium soaps in vitreous body. This benign condition has been reported to be frequently associated to many systemic disorders including diabetes mellitus, systemic arterial hypertension, atherosclerotic vascular disease, hypercholesterolemia and increased serum calcium levels. We report an unusual case of bilateral asteroid hyalosis revealing a diabetes in a previously healthy man. A 65-year old man presented with 2 years history of increasing bilateral eye floaters. -
(12) United States Patent (10) Patent No.: US 7.873,482 B2 Stefanon Et Al
US007873482B2 (12) United States Patent (10) Patent No.: US 7.873,482 B2 Stefanon et al. (45) Date of Patent: Jan. 18, 2011 (54) DIAGNOSTIC SYSTEM FOR SELECTING 6,358,546 B1 3/2002 Bebiak et al. NUTRITION AND PHARMACOLOGICAL 6,493,641 B1 12/2002 Singh et al. PRODUCTS FOR ANIMALS 6,537,213 B2 3/2003 Dodds (76) Inventors: Bruno Stefanon, via Zilli, 51/A/3, Martignacco (IT) 33035: W. Jean Dodds, 938 Stanford St., Santa Monica, (Continued) CA (US) 90403 FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 WO WO99-67642 A2 12/1999 U.S.C. 154(b) by 158 days. (21)21) Appl. NoNo.: 12/316,8249 (Continued) (65) Prior Publication Data Swanson, et al., “Nutritional Genomics: Implication for Companion Animals'. The American Society for Nutritional Sciences, (2003).J. US 2010/O15301.6 A1 Jun. 17, 2010 Nutr. 133:3033-3040 (18 pages). (51) Int. Cl. (Continued) G06F 9/00 (2006.01) (52) U.S. Cl. ........................................................ 702/19 Primary Examiner—Edward Raymond (58) Field of Classification Search ................... 702/19 (74) Attorney, Agent, or Firm Greenberg Traurig, LLP 702/23, 182–185 See application file for complete search history. (57) ABSTRACT (56) References Cited An analysis of the profile of a non-human animal comprises: U.S. PATENT DOCUMENTS a) providing a genotypic database to the species of the non 3,995,019 A 1 1/1976 Jerome human animal Subject or a selected group of the species; b) 5,691,157 A 1 1/1997 Gong et al. -
V.B.8. Paradigms
Vitreous Floaters and Vision: Current Concepts and Management V.B.8. Paradigms Laura C. Huang, Kenneth M.P. Yee, Christianne A. Wa, Justin N. Nguyen, Alfredo A. Sadun, and J. Sebag Outline Keywords I. Introduction Vitreous • Floaters • Posterior vitreous detachment • II. Background Myopic vitreopathy • Asteroid hyalosis • Light scatter- A. Etiology of Floaters ing • Straylight glare • Contrast sensitivity • VFQ III. Diagnostic Considerations quality of life • Vitrectomy • Retinal detachment • A. Clinical Presentation Oxygen • Cataracts B. Clinical Characterization of Floaters 1. Structural Assessment of Floaters a. Ultrasonography b. Combined OCT/SLO c. Dynamic Light Scattering Key Concepts 2. Effects of Floaters on Vision 1. Floaters result from structural abnormalities in vit- a. Straylight reous. They are a more common complaint than b. Contrast Sensitivity Function previously known and have a more negative impact IV. Therapeutic Considerations on the quality of life than previously appreciated. A. Vitrectomy 1. Efficacy of Vitrectomy for Floaters 2. Vision is adversely affected by vitreous light scat- 2. Safety of Vitrectomy for Floaters tering causing straylight glare and degradation of a. Endophthalmitis contrast sensitivity. This explains the considerable b. Retinal Tears and Retinal Detachment degree of unhappiness experienced by patients suf- c. Cataracts fering from floaters. Conclusions 3. The only proven and safe treatment that effectively References cures floaters and improves vision as well as patient well-being is limited vitrectomy. L.C. Huang, BA VMR Institute for Vitreous Macula Retina, 7677 Center Avenue, suite 400, Huntington Beach, CA 92647, USA Doheny Eye Institute, Department of Ophthalmology, Los Angeles, CA, USA University of Miami Miller School of Medicine, Miami, FL, USA e-mail: [email protected] K.M.P.